Health Condition 1: N801- Endometriosis of ovary Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Endometrioma size 3 to 6 centimeters Infertility with unilateral and bilateral endometrioma W ii lling to sign informed and written consent
Exclusion criteria
Exclusion criteria: Refusal to consent Premature ovarian insufficiency On going medical therapy for endometriosis Active pelvic infection Ultrasound showing signs of malignancy Very high CA 125 level( >100U/ml),CEA( >10ng/ml),CA19.9( >30U/ml)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1)Change in size of endometrioma pre and post sclerotherapy (2)ovarian reserve in terms of a. Serum AMH b.Antral follicle count Pre and post intervention 1,2 and 3 months (3) In those women with optimal reserve at follow up visit a. Total dose of gonadotropin requirement b.Number of Oocytes retreived c.quality of the oocytes d.Fertilization rate e.Cleavage rate Timepoint: Maximum 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| (1)ovarian reserve in terms of a. Serum AMH b.Antral follicle count Pre & post intervention 1,2 & 3 months (2) Comparison of IVF outcomes between the sclerotherapy & expectant management groups a. Total dose of gonadotropin requirement b.Number of Oocytes retreived & fertilized c.Implanation rate d. Live birth rate Timepoint: 1 to 3 months from intervention. Maximum 3 months period. After AFC & antral follicle count optimum posted for IVF | — |
Countries
India
Contacts
All India Institute of Medical Sciences (AIIMS Delhi)